(Q40932197)

English

Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.

scientific article published on 14 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

hospitalization

1 reference

based on heuristic

inferred from title

Marie-Josée J Mangen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Tjip S van der Werf

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Maarten J. Postma

5

object named as

Maarten J Postma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Mark H Rozenbaum

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Susanne M Huijts

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

0 references

publication date

14 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

3193-3199

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981488%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Burden of community-acquired pneumonia in North American adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Clinical and economic burden of community-acquired pneumonia among adults in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Increasing hospital admissions for pneumonia, England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Efficacy of pneumococcal vaccination in adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Classification algorithms to improve the accuracy of identifying patients hospitalized with community-acquired pneumonia using administrative data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.001

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40932197&oldid=1518242429"